October 16, 2013
Multiple Sclerosis: Functional change in brain as cause of cognitive disorders
- /
- /
Over the course of the disease, multiple sclerosis is very often combined with a deteriorating memory and attention deficits. Researchers…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
October 13, 2013
Einstein’s brain a wonder of connectedness
- /
Information provided by Nina F., in Florida Theoretical physicist Albert Einstein had a brain that was not only bigger in…
October 13, 2013
Oct 13, 2013 – New therapy gives hope to Multiple Sclerosis Patients
- /
- /
New strategy to treat multiple sclerosis shows promise in mice The new study showed the drug benztropine led to the…
October 12, 2013
Three Major Advances in Multiple Sclerosis – Discussed at ECTRIMS 2013
- /
ECTRIMS : European Committee for Treatment and Resources in Multiple Sclerosis Three Major Advances in Multiple Sclerosis Andrew N. Wilner,…
October 12, 2013
Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis
- /
Oct 10, 2013 Genmab A/SCompany AnnouncementGenmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple SclerosisCompany Announcement —…
October 11, 2013
Teva: Laquinimod reduces brain damage in MS patients
- /
- /
- /
Teva CSO: Laquinimod might also help treat Crohn’s disease, lupus nephritis, Huntington’s disease and Alzheimer’s. Teva Pharmaceutical Industries Ltd. and Active…
October 9, 2013
New technique for imaging myelin loss and repair shows potential for identifying compounds with future potential to treat MS
- /
- /
Oct 03, 2013 Researchers in Cleveland and London, funded by the National MS Society have achieved a new way to…
October 9, 2013
Test May Suggest Tysabri for More MS Patients
- /
- /
October 7, 2013 COPENHAGEN — A blood test for L-selectin expression on circulating immune cells may identify multiple sclerosis…
October 8, 2013
Teva to Present Further Results of Twenty-Year Open-Label Extension Study of Glatiramer Acetate 20 mg Daily for Relapsing-Remitting Multiple Sclerosis
- /
Glatiramer acetate (GA) 20 mg daily associated with stable disease activity over the course of the twenty-year study presented at…
October 8, 2013
SHOP.COM Now Partners with MS VIEWS and NEWS
- /
SHOP.COM Now Partners with MS VIEWS and NEWS MS Views and News is proud to announce their partnership with online powerhouse…
